In what amounts to an outrageous power-grab, the U.S. FDA is saying that the stem cells within your own body are drugs. They further claim that stem cell therapy counts as interstate commerce because it affects the profits of FDA-approved drugs in other states.
These ridiculous arguments are the result of the FDA’s ongoing battle with the Centeno-Schultz Clinic in Colorado over a non-surgical treatment called Regenexx-SD, which treats people suffering from moderate to severe joint or bone pain using adult stem cells. The clinic takes your own blood and puts it into a centrifuge machine that separates out the stem cells, and then a doctor puts them back in your body where there is damaged tissue.
The Alliance for Natural Health reports:
“This time the FDA just nakedly says in court documents that the agency wants to protect the market for FDA-approved drugs. No more beating around the bush -- their agenda is right out in the open! This appears to be a novel interpretation of the Food Drug and Cosmetic Act (FD&C), as evidenced by the government’s failure to cite any judicial precedent for their argument ... The clinic has argued numerous times that stem cells aren’t drugs because they are components of the patient’s blood from his or her own body.”